Huang et al. 202017
|
41 |
Prospective |
49 (41-58) |
-
- DM: 8 (20%)
-
- AH: 6 (15%)
-
- CVD: 6 (15%)
-
- COPD: 1 (2%)
-
- Cancer: 1 (2%)
|
-
- 13 (32%) ICU admissions
-
- 5 (12%) MI, and 4 (31%) to the ICU
-
- 3 (7%) shock and 12 (29%) ARDS
-
- Mortality: 6 (15%)
|
Wang et al. 202030
|
69 |
Retrospective |
42 (35-62) |
-
- AH: 9 (13%)
-
- CVD: 8 (12%)
-
- DM: 7 (10%)
-
- COPD: 4 (6%)
-
- Cancer: 4 (6%)
|
|
Chen et al. 202031
|
99 |
Retrospective |
55 (21-82) |
-
- CVD: 40 (40%)
-
- DM: 12 (12%)
-
- Cancer: 1 (1%)
|
-
- 57 (58%) hospitalizations, 17 (17%) ARDS, 4 (4%) shock
-
- Mortality: 11 (11%)
-
- Of the deceased, 63% were > 60 years and 33% had AH
|
Wang et al. 20209
|
138 |
Retrospective |
56 (42-68) |
-
- AH: 43 (31.2%)
-
- CVD: 20 (14.5%)
-
- DM: 14 (10.1%)
-
- Cancer: 10 (7.2%)
-
- Stroke: 7 (5.1%)
|
-
- 36 (26%) ICU admissions, high prevalence of risk factors
-
- 12 (8.7%) shock, 23 (16.7%) arrhythmias, 27 (19.6%) ARDS, and 10 (7.2%) MI
-
- Mortality: 6 (4.3%)
|
Zhang et al. 202029
|
140 |
Retrospective |
57 (20–83) |
|
-
- Comparing severe x non-severe groups: median age 64 vs 51.5, p < 0.001 comorbidities 79.3% vs 53.7%, p = 0.002 d-dimer 0.4 vs 0.2, p<0.001
|
Guo et al. 202010
|
187 |
Retrospective |
58.5 (±14.7) |
-
- AH: 61 (32.6%)
-
- CAD: 21 (11.2%)
-
- HF: 8 (4.3%)
-
- DM: 28 (15%)
-
- COPD: 4 (2.1%)
-
- Cancer: 13 (7%)
|
-
- 52 (27.8%) MI
-
- Comparing normal tropo x high tropo: AH: 27% vs 63.5%, p 0.001 CAD: 3% vs 32.7%, p <0.001 HF: 0% vs 15.4%, p <0.001
-
- 43 deaths, 31 (59.6%) in the MI group
-
- Mortality: 13.3% CVD without MI, and 69.4% CVD with MI
|
Zhou et al 202012
|
191 |
Retrospective |
56 (46-67) |
-
- AH: 58 (30%)
-
- DM: 36 (19%)
-
- CAD: 15 (8%)
-
- COPD: 6 (3%)
-
- Cancer: 2(1%)
|
-
- MI: 24/145 (17%), greater in patients who died (22.2 [5.6-83.1] vs 3.0 [1.1-5.5], p <0.001)
-
- HF 44 (23%), shock 38 (20%), ARDS 59 (31%)
-
- 54 (28%) deaths, 67% with comorbidities
|
Shi et al. 202011
|
416 |
Prospective |
64 (21-95) |
-
- AH: 127 (30.5%)
-
- DM: 60 (14.4%)
-
- CAD: 44 (10.6%)
-
- Stroke: 22 (5.3%)
-
- HF: 17 (4.1%)
-
- Cancer: 9 (2.2%)
|
-
- 82 (19.7%) MI
-
- High prevalence of AH, DM, CAD and HF in patients with MI
-
- MI was related to higher mortality: (42 of 82 [51.2%] vs 15 of 334 [4.5%]; p < .001)
-
- MI was associated with ARDS: (48 of 82 [58.5%] vs 49 of 334 [14.7%]; p < .001)
|
Guan et al. 202032
|
1099 |
Retrospective |
47 (35-58) |
-
- COPD: 12 (1.1%)
-
- DM: 81 (7.4%)
-
- AH: 165 (15%)
-
- CAD: 27 (2.5%)
-
- Stroke: 15 (1.4%)
-
- Câncer: 10 (0.9%)
|
-
- Severely-ill patients: AH 41 (23.7%)
-
- High CK-MB 90/657 (13.7%)
-
- 12 (1.1%) shock, 37 (3.4%) ARDS, 1029 (93.6%) hospitalizations, 55 (5%) ICU admissions
-
- Mortality: 15 (1.4%)
|